Live Nasdaq Composite: Market Sentiment Remains Hopeful on Cooling Inflation Signals, AI Earnings

Investing

Eli Lilly : LLY

All Eli Lilly Articles

678 Articles

David Beren | Jul 9, 2026 at 12:18 PM EDT

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is the default healthcare allocation for millions of investors, and for good…

Ian Cooper | Jul 9, 2026 at 11:35 AM EDT

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

CNBC’s Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter. Instead, he highlighted a group he says…

Joel South | Jul 9, 2026 at 8:00 AM EDT

3 High Growth GLP-1 Biotech Winners to Buy in July

The GLP-1 trade has matured from a single-stock story into a tiered opportunity set. Demand for obesity therapeutics keeps expanding…

Rich Duprey | Jul 8, 2026 at 12:02 PM EDT

Wall Street Is Betting on Eli Lilly’s GLP-1 Portfolio — It’s Missing the $1 Trillion Opportunity

The pharmaceutical industry is entering a new era where biology and artificial intelligence are converging. Drug discovery, once a slow…

Chris MacDonald | Jul 8, 2026 at 8:42 AM EDT

This $1,200 Stock Could Be the Next Massive Stock Split Opportunity

The Number $8.662 billion. That is what Mounjaro alone generated for Eli Lilly (NYSE:LLY | LLY Price Prediction) in the…

Omor Ibne Ehsan | Jul 7, 2026 at 2:55 PM EDT

Everyone Thinks the Eli Lilly Story Is Played Out. Cramer Thinks They’re Dead Wrong

Drug stocks got hit hard on Monday in what Jim Cramer called a “vicious rotation,” and the selloff looked like…

Thomas Richmond | Jul 7, 2026 at 12:30 PM EDT

Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”

On CNBC’s Mad Dash segment on Monday, July 6, 2026, Jim Cramer made one of his most bullish biotech calls…

Vandita Jadeja | Jul 4, 2026 at 2:00 PM EDT

Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly

Eli Lilly (NYSE:LLY | LLY Price Prediction) and Johnson & Johnson (NYSE:JNJ) just reported Q1 2026 results that read like…

Vandita Jadeja | Jul 1, 2026 at 1:18 PM EDT

Eli Lilly Price Prediction: The Case for Double-Digit Upside

Our 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,349.37, pointing to 12.5% upside…

Omor Ibne Ehsan | Jul 1, 2026 at 11:50 AM EDT

New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks

If you sort all the top politicians with a portfolio of above $1 million using their annual gains, who do…

Rich Duprey | Jun 30, 2026 at 9:38 AM EDT

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from Silicon Valley. Biotechnology…

Vandita Jadeja | Jun 22, 2026 at 4:02 PM EDT

Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow

Eli Lilly (NYSE: LLY | LLY Price Prediction) and Pfizer (NYSE: PFE) just delivered Q1 2026 results that read like…

Marc Guberti | Jun 21, 2026 at 4:17 PM EDT

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

The Health Care Select Sector SPDR ETF (NYSEARCA:XLV) is having a frustrating year. The fund sits at $149, down about…

Vandita Jadeja | Jun 19, 2026 at 3:15 PM EDT

Prediction: Eli Lilly Will Trade at $1,200 on This Date

Eli Lilly (NYSE:LLY | LLY Price Prediction) just reported a quarter that should have sent bulls into a frenzy. Revenue…

Alex Sirois | Jun 12, 2026 at 10:47 AM EDT

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to own right now, a $1.02 trillion obesity…

1 2 3 4 … 46

Eli Lilly : LLY

All Eli Lilly Articles

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

3 High Growth GLP-1 Biotech Winners to Buy in July

Wall Street Is Betting on Eli Lilly’s GLP-1 Portfolio — It’s Missing the $1 Trillion Opportunity

This $1,200 Stock Could Be the Next Massive Stock Split Opportunity

Everyone Thinks the Eli Lilly Story Is Played Out. Cramer Thinks They’re Dead Wrong

Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”

Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly

Eli Lilly Price Prediction: The Case for Double-Digit Upside

New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

Prediction: Eli Lilly Will Trade at $1,200 on This Date

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

Live Nasdaq Composite: Market Sentiment Remains Hopeful on Cooling Inflation Signals, AI Earnings

Live: Will Coherent Crush Q4 Earnings After Soaring 9% Today?

Live: Will Cisco’s Q4 Earnings Tonight Continue the Stock’s 61% YTD Rally?

United States Antimony Plummets 25% After Slashing 2026 Guidance on Plunging Antimony Prices

Why XRP Whales Keep Buying as the Price Falls. Is a Bull Rally Coming?

SpaceX Just Unveiled Grok 4.6. Musk Calls it “Objectively #1” In AI. Anthropic, OpenAI and This Stock May Be in Trouble.

Make Sure You're Using Your 401(k)'s After-Tax Bucket Before Maxing Out Pretax Contributions

The $32,000 Line Hasn't Moved Since 1984. It's Why More of Your Social Security Gets Taxed Every Year.

Live: Will Coherent Crush Q4 Earnings After Soaring 9% Today?

United States Antimony Plummets 25% After Slashing 2026 Guidance on Plunging Antimony Prices

Eli Lilly : LLY

All Eli Lilly Articles

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

3 High Growth GLP-1 Biotech Winners to Buy in July

Wall Street Is Betting on Eli Lilly’s GLP-1 Portfolio — It’s Missing the $1 Trillion Opportunity

This $1,200 Stock Could Be the Next Massive Stock Split Opportunity

Everyone Thinks the Eli Lilly Story Is Played Out. Cramer Thinks They’re Dead Wrong

Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”

Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly

Eli Lilly Price Prediction: The Case for Double-Digit Upside

New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

Prediction: Eli Lilly Will Trade at $1,200 on This Date

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy

Live Nasdaq Composite: Market Sentiment Remains Hopeful on Cooling Inflation Signals, AI Earnings

Live: Will Coherent Crush Q4 Earnings After Soaring 9% Today?

Live: Will Cisco’s Q4 Earnings Tonight Continue the Stock’s 61% YTD Rally?

United States Antimony Plummets 25% After Slashing 2026 Guidance on Plunging Antimony Prices

Why XRP Whales Keep Buying as the Price Falls. Is a Bull Rally Coming?

SpaceX Just Unveiled Grok 4.6. Musk Calls it “Objectively #1” In AI. Anthropic, OpenAI and This Stock May Be in Trouble.

Featured Reads

Make Sure You're Using Your 401(k)'s After-Tax Bucket Before Maxing Out Pretax Contributions

The $32,000 Line Hasn't Moved Since 1984. It's Why More of Your Social Security Gets Taxed Every Year.